Neuphoria Therapeutics Inc. Restricted Cash, Current
Neuphoria Therapeutics Inc. (NEUP) had Restricted Cash, Current of $79.65 thousand as of 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2026-09-18
- 2025-12-31: Restricted Cash, Current $79.65K.
- 2025-09-30: Restricted Cash, Current $78.56K.
- 2025-06-30: Restricted Cash, Current $77.94K.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-12-31 | $79.65K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $78.56K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $77.94K 10-K · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |